In several circumstances in hemodialysis, the regular direction of blood flow has to be reversed or changed, such as in access dysfunction or insufficient blood flow being obtained through the arterial port, as well as to measure actual access blood flow in fistulas or grafts by using the formula Qa = Qb((1-R)/R), where R represents recirculation in the reversed line configuration. We invented a disposable switch device made from standard blood line tubing that can be introduced into the dialysis circuit and allows for on-line reversal of lines, without needing to manually disconnect and reconnect tubing or interrupt the hemodialysis procedure. Over a period of eight months, 16 patients (8 arteriovenous fistula, 8 PTFE) underwent 193 hemodialysis sessions with the switch in place. Circuit pressures, pump, and actual blood flows measured with ultrasound dilution were monitored before and after reversing the lines. Switching was accomplished within 1-2 seconds. Arterial circuit (r = 0.99), venous circuit pressures (r = 0.6), and actual pump flow (364 +/- 56 vs. 350 +/- 57 ml/min; r = 0.73) correlated very well preswitching and postswitching (p < 0.0001). Dialysis circuit flow measured with an ultrasound dilution technique decreased from 364 +/- 56 (230-480) ml/min preswitching to 350 +/- 57 (220-490) ml/min postswitching (p < 0.001). No difficulties or complications were observed. This switch device is a useful addition to the technology of hemodialysis in that it greatly facilitates the procedure of reversing the lines in an extracorporeal circuit while not significantly interfering with circuit pressures and connections.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.